TScan Therapeutics

View the org chart displaying its 18 main executives

Most searched biographies at TScan Therapeutics

• Gavin MacBeath, Chief Executive Officer
• Gabriela Gruia, Director
• Timothy Barberich, Chairman of the Board

Popular executive movements at TScan Therapeutics

• Jason Amello has joined the company as Chief Financial Officer  (posted on January 30 2024).
• Keith Woods has joined the company as Director  (posted on December 7 2023).
• Justin McCue has joined the company as Chief Technology Officer  (posted on December 4 2023).

Create your alert
to follow the executive moves at TScan Therapeutics.

TScan Therapeutics has 1,820 competitors including Siemens Healthineers (Germany), IQVIA (United States (USA)) and Saint Francis Health System (United States (USA)).

Popular M&A news in Healthcare

• Rad AI has just announced a $50 Million fundraising (posted on May 7 2024).
• Midi Health has just announced a $60 Million fundraising (posted on April 29 2024).
• Xaira Therapeutics becomes a unicorn with its fundraising of $1,000 Million. (posted on April 25 2024).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Ralph De La Torre - Chairman and Chief Executive Officer at Steward Health Care
• Bryan Roberts - Director at Included Health

Learn more about the Healthcare industry >

Press releases by TScan Therapeutics

• TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update | TScan Therapeutics, Inc.
• TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition | TScan Therapeutics, Inc.
• TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting | TScan Therapeutics, Inc.
• TScan Therapeutics Announces Upcoming Presentations at the 38th Society for Immunotherapy of Cancer Annual Meeting | TScan Therapeutics, Inc.
• TScan Therapeutics to Participate in Upcoming Investor Conferences | TScan Therapeutics, Inc.
• TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-203-A0201 Targeting PRAME | TScan Therapeutics, Inc.
• TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update | TScan Therapeutics, Inc.
• Press Releases | TScan Therapeutics, Inc.
• Press Releases | TScan Therapeutics, Inc.
• TScan Therapeutics Announces Transition of Chief Financial Officer | TScan Therapeutics, Inc.
• View more press releases Close

Social media about TScan Therapeutics

• TScan Therapeutics on Wikipedia, Google News & Yahoo Finance
• TScan Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Timothy Barberich

Call TScan Therapeutics at +1 857...

View the org chart

Register to receive your alert

Report an error